[ad_1]
There is widespread concern that there are disparities between nations in the availability of the new vaccine against coronavirus infection (COVID19). This is because the spread of the infection will not stop and dangerous variants will be born, which will make drugs and vaccines less effective, which can further reduce the economy.
Rich countries are already benefiting from the vaccine as countries scramble to respond to the new variants – the United States, Britain, and the European Union (EU) so farAdministers 24 million doses to residents, which represents more than half of the world total. On the other hand, in most countries, inoculation has not yet started.
The imbalance in the acquisition of immunity poses a threat to both “have countries” and “have not countries”. Not only will the cumulative death toll exceed 2 million, but it will also allow time for the virus to evolve and produce new mutations, which could have huge economic and public health consequences.
Uneven distribution
High-income countries have secured 85% of Pfizer’s vaccine and all of Moderna’s
Source: Airfinity
Charlie Weller from Medical Charity Welcome
Photographer: Thomas SG Farnetti
Oversees the vaccine industry at the Welcome medical charity“We cannot leave behind countries that do not have access to vaccines, and if we do, we will recover,” warned Charlie Weller. “People all over the world are at risk,” he said.
To save lives and revitalize the economy, every country depends on effective immunization.The 4% growth expected by the World Bank this year presupposes a wide dissemination of the vaccine. If the infection spreads and vaccination is delayed, the growth rate may be only 1.6%.
British research companyAccording to Affinity, high-income countries have purchased 85% of Pfizer vaccines from the US and all Moderna vaccines from the US Other countries will depend on vaccines from other manufacturers, such as AstraZeneca, which are cheap and easy to use. distribute, or Kakou Holding Biotechnology of China (Sinobac Biotech).
Of the 42 countries that have started vaccination as of the 8th of this month, 36 are high-income countries and the rest are middle-income countries, said Tedros, secretary general of the World Health Organization (WHO). In addition to participating in the WHO-led joint purchasing framework “COVAX”, an increasing number of countries are moving to conclude their own supply contracts.
Original title:
Vaccine disparities raise alarm as Covid variants multiply （抜 粋）
